ABT
Abbott’s new health buddy
Abbott is linking arms with Google Health in a multi-year collaboration that sounds a little like your smartwatch finally got a nutritionist. The two companies want to fuse Lingo glucose insights with Google Health’s tech so people can get a more complete picture of how food, sleep, stress, and activity mess with their bodies.
Why investors should care
This isn’t just a shiny app feature. Abbott says the partnership includes a large-scale research study, which could help improve the AI coaching inside the Google Health app and shape future Lingo features. In plain English: more data, more personalization, and potentially more reasons for consumers to keep paying attention to Abbott’s over-the-counter CGM.
The bigger play
Lingo is Abbott’s attempt to make glucose monitoring feel less like a hospital device and more like a wellness tool you’d actually use. Teaming up with Google gives Abbott a heavyweight tech ally and a chance to expand Lingo’s relevance beyond diabetes management into everyday health optimization.
- Abbott gets a distribution and AI credibility boost.
- Google Health gets real-world glucose data to sharpen coaching.
- Consumers get a more “how your body actually works” kind of product.
Big picture: if this works, Abbott may be building a nicer-looking on-ramp from medical device company to consumer health platform. And that’s the kind of pivot Wall Street likes to squint at a little harder.